Skip to main content

Residual Tumor After Biopsy in Cutaneous Malignancies (Thompson et al.)

Jackett LA, Satgunaseelan L, Roper E, et al.
Dermatologic Surgery (2022)

JC: January 2025

This study by Thompson et al. evaluated the rate of residual tumor found at the time of definitive excision after diagnostic biopsy in cutaneous malignancies. The findings quantified how often residual tumor remains at the biopsy site and its implications for surgical planning and margin assessment.

Take-Home Messages

  • Residual tumor is frequently present at biopsy sites of cutaneous malignancies, supporting the need for definitive surgical treatment even after apparently complete biopsies.
  • Biopsy technique and tumor type influence the likelihood of residual tumor, which should be considered in surgical planning.

Topic

Mohs Technique & Outcomes

Mohs micrographic surgery indications, outcomes, and procedural refinements

Related MohsPedia Articles

Abstract

Wide local excision (WLE) to achieve adequate clearance margins is the standard initial definitive treatment for patients with biopsy-proven primary cutaneous melanoma. Residual melanoma in WLE specimens after prior complete excision-biopsy (CEB) is reported in 0-6.3% of cases. However, studies evaluating the prevalence, clinicopathological features and relevance of persistent disease in WLE specimens are limited. This study sought to determine the frequency of and clinicopathological charact...

Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.